Ordering
Available Variants50 mg
CHA.73107-50mg
Price
€104.80
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
50 mg | CHA.73107-50mg | €104.80 |
≥97% (HPLC), powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C7H11N3NaO6S |
|---|---|
| CAS Number | 1192491-61-4 |
| Molecular Weight | 288.23 |
| UNSPSC Code | 51101500 |
| NACRES | NA.41 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Avibactam sodium salt, with a CAS number of 1192491-61-4, is a synthetic beta-lactamase inhibitor that has garnered significant attention in the realm of antimicrobial therapy. This compound functions by covalently binding to beta-lactamase enzymes, thereby preventing the inactivation of beta-lactam antibiotics. As a result, avibactam sodium salt is often combined with various antibiotics to enhance their efficacy against beta-lactamase-producing bacteria. The mechanism of action of avibactam involves the formation of a stable acyl-enzyme complex, which effectively inactivates the beta-lactamase enzyme. This inhibition restores the antibacterial activity of the paired antibiotic, allowing for the effective treatment of infections caused by multidrug-resistant bacteria. The use of avibactam sodium salt has been shown to be a valuable strategy in combating antibiotic resistance, and its applications continue to be explored in clinical settings.
